Prevention of hepatitis development by interferon-alpha in HBV carriers treated with intensive chemotherapy: A pilot study

被引：6

作者：

Kumagai, K ^{[1
]}

Takagi, T ^{[1
]}

Sakai, C ^{[1
]}

机构：

[1] Chiba Canc Ctr Hosp, Hematol Chemotherapy Div, Chuoh Ku, Chiba 260, Japan

来源：

ANNALS OF ONCOLOGY | 1998年 / 9卷 / 01期

关键词：

D O I：

10.1023/A:1008216716778

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：117 / 118

页数：2

共 7 条

[1]

GALBRAITH RM, 1975, LANCET, V2, P528

[2] REACTIVATION OF CHRONIC HEPATITIS B-VIRUS INFECTION BY CANCER-CHEMOTHERAPY [J].

HOOFNAGLE, JH ;

DUSHEIKO, GM ;

SCHAFER, DF ;

JONES, EA ;

MICETICH, KC ;

YOUNG, RC ;

COSTA, J .

ANNALS OF INTERNAL MEDICINE, 1982, 96 (04) :447-449

[3] Hepatitis B virus carriers in the treatment of malignant lymphoma: An epidemiological study in Japan [J].

Kumagai, K ;

Takagi, T ;

Nakamura, S ;

Sawada, U ;

Kura, Y ;

Kodama, F ;

Shimano, S ;

Kudoh, I ;

Nakamura, H ;

Sawada, K ;

Ohnoshi, T .

ANNALS OF ONCOLOGY, 1997, 8 :107-109

[4]

KUMAGAI K, 1993, JPN J CLIN HEMATOL, V34, P1587

[5]

PINTO PC, 1990, CANCER-AM CANCER SOC, V65, P878, DOI 10.1002/1097-0142(19900215)65:4<878::AID-CNCR2820650409>3.0.CO

[6]

2-K

[7]

WANDS JR, 1975, LANCET, V2, P979

← 1 →